Qube Research & Technologies (QRT)
LXRX icon

Qube Research & Technologies (QRT)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-277,248
Closed -$302K – 4570
2023
Q3 		$302K Buy
277,248
+204,005
+279% +$358K ﹤0.01% 2242
2023
Q2 		$168K Buy
73,243
+12,520
+21% +$33.2K ﹤0.01% 1826
2023
Q1 		$148K Buy
+60,723
New +$139K ﹤0.01% 2027
2021
Q2 		– Sell
-20,490
Closed -$120K – 2586
2021
Q1 		$120K Buy
+20,490
New +$142K ﹤0.01% 1726
2020
Q2 		– Sell
-29,183
Closed -$57K – 1880
2020
Q1 		$57K Buy
+29,183
New +$86.9K ﹤0.01% 1012

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LXRX Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2023, closing a stake of 277,248 shares — an estimated $302K sold.

Qube Research & Technologies (QRT) first reported a position in LXRX in Q1 2020 and held it in 5 quarters. The position peaked at $302K in Q3 2023. 106 funds tracked by Wall St. Rank hold LXRX as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Lexicon Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 277,248 Lexicon Pharmaceuticals shares in Q4 2023, an estimated $302K.
  • Qube Research & Technologies (QRT) first reported a position in Lexicon Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Lexicon Pharmaceuticals position peaked at $302K in Q3 2023.
  • 106 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.